Alternatively, the conjugation strategy of CLB-ZW800 may be reconsidered to allow the CLB moiety to remain in the tumor microenvironment through the reactive oxygen species (ROS)-triggered activation process using a cleavable disulfide linker. The gene discussed is CLYBL; the disease is neoplasm.